Thrombosis, a major cause of deaths in this modern era responsible for 31% of all global
deaths reported by WHO in 2017, is due to the aggregation of fibrin in blood vessels which …

Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily
attributed to excessive fibrin accumulation in the blood vessels, usually consequential in …

Fibrinolytic enzymes are proteases responsible for cleavage of fibrin mesh in thrombus clots,
which are the primary causative agents in cardiovascular diseases. Developing safe …

With the dramatic increase in mortality of cardiovascular diseases (CVDs) caused by
thrombus, this has sparked an interest in seeking more effective thrombolytic drugs or …

Fibrinolytic enzymes cleave fibrin which plays a crucial role in thrombus formation which
otherwise leads to cardiovascular diseases. While different fibrinolytic enzymes have been …

Despite recent advances in recanalization therapy, mechanical thrombectomy will never be
a treatment for every ischemic stroke because access to mechanical thrombectomy is still …

Abstract Cochliobolus hawaiiensis Alcorn Assiut University Mycological Centre 8606 was
chosen from the screened 20 fungal species as the potent producer of fibrinolytic enzyme on …

Microbial fibrinolytic proteases are therapeutic enzymes responsible to ameliorate
thrombosis, a fatal cardiac-disorder which effectuates due to excessive fibrin accumulation …

Fibrinolytic activity assay is particularly important for the detection, diagnosis, and treatment
of cardiovascular disease and the development of fibrinolytic drugs. A novel efficacious …

A novel fibrinolytic enzyme, BSFE1, was isolated from the marine bacterium Bacillus sp. S-
3685 (GenBank No.: KJ023685) found in the South China Sea. This enzyme, with a …